CatalystPit

BHVNBiohaven Ltd.

NYSE · PHARMACEUTICAL PREPARATIONS
Last close $13.35 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$2.02B
CountryUSA
RECENT INSIDER TRADES
  • 2026-03-19 · Mehta Kishan (Director) · OTHER
  • 2025-11-18 · Clark George C. (VP, Chief Accounting Officer) · BUY
  • 2025-11-17 · Coric Vlad (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders94
Shares held74,481,075
Value$1.21B
Percent of shares outstanding49.31%
As of quarter end2026-06-30
RECENT NEWS
  • Biohaven Pharma stock maintained at buy by Canaccord on licensing deal
  • Biohaven licenses IgG degrader portfolio to Japan’s Ono
  • Biohaven licenses IgG degrader portfolio to Ono for Asia
  • Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions
  • Biohaven selected to present Phase 1 data on BHV-1530 at EORTC-NCI-AACR Symposium 2026
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Biohaven Ltd. (BHVN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit